Person › Details

Holger Reithinger (Forbion Capital Partners Germany GmbH)

Reithinger, Holger (Forbion 201004– Managing Director Forbion Capital Partners Munich before GLSV Munich + 3i Germany)

	Organisation	Forbion Capital Partners Germany GmbH
	Group	Forbion Capital Partners (NL)
	Former/major organisation	Global Life Science Ventures GmbH
	Group	Global Life Science Ventures (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES

Record changed: 2020-11-12

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Holger Reithinger

[1] Gotham Therapeutics Corporation. (10/10/18). "Press Release: Gotham Therapeutics Launches with $54 Million Series A". New York, NY....
[2] Forbion Capital Partners. (10/10/18). "Press Release: Forbion Co-leads $54m Series A Financing in Newly Formed Gotham Therapeutics". Naarden & Munich....
[3] Curetis N.V.. (4/30/18). "Press Release: Curetis Announces Change of the Composition of Its Supervisory Board. Dr. Holger Reithinger Resigns as Member of the Supervisory Board". Amsterdam, San Diego, CA & Holzgerlingen....
[4] Curetis N.V.. (5/24/17). "Press Release: Curetis Provides Business and Financial Update for the First Quarter 2017". Amsterdam & Holzgerlingen....
[5] Forbion Capital Partners. (6/16/16). "Press Release: FCF II Co-Invest I Supports EUR 22M Series B of Allecra Therapeutics". Munich & Naarden....
[6] Allecra Therapeutics GmbH. (6/15/16). "Press Release: Allecra Therapeutics Announces €22 Million Series B Financing". Lörrach & Saint Louis....
[7] KfW. (5/19/15). "Press Release: KfW Strengthens Germany’s Technological Competitiveness with New Venture Capital Product. First Funds Invested in Forbion FCF III Life Sciences Fund"....
[8] High-Tech Gründerfonds Management GmbH. (3/24/15). "Press Release: Rigontec GmbH Raises €4.8m in a Second Closing of Its Series A Financing. Brings Series A Total to €14.25m to Advance RNA-based Immunotherapeutics for Cancer and Viral Diseases"....
[9] Curetis AG. (10/26/11). "Press Release: Curetis AG Attracts Forbion and Roche as New Investors. Series A Financing Round Expanded to €34.1 Million". Holzgerlingen....
[10] Forbion Capital Partners. (1/22/11). Web Site: About Us – Strategy – Team – Experience – Investment Philosophy – Investment Criteria – Investment Process – Our Portfolio. [http://www.forbion.com, 01/22/11]...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]